We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

Roche Files IND for Genmab Antibody

Genmab utilizes Roche’s broad antibody expertise and development capabilities to create human antibodies.
News

Researchers Discover High Prevalence of Genomic Deletions Between Humans

The discovery shows how people differ in their risk of disease or their response to drugs.
News

NIH Launches Comprehensive Effort to Explore Cancer Genomics

The Cancer Genome Atlas begins with three-year, $100 million pilot project.
News

MorphoSys Signs Agreement for Use of Antibody Technologies with Merck & Co.

The agreement enables Merck to develop HuCAL®-derived therapeutic antibodies in a range of indications.
News

Fujitsu Announces Evaluation Project with Whitehead Institute

Fujitsu will provide Whitehead with the CELLINJECTOR automated microinjection system.
News

Antibodies Now Available Directly From the Source

Seven Hills Bioreagents eliminates the need to deal with resellers.
News

Scientists Unlock Solid Tumor Treatment Genetic Secrets

The investigators found evidence that suggests hypoxia-inducible factor might activate genes by a third type of biochemical pathway.
News

Researchers Identify Genetic Variations Associated With Predisposition to Myeloma and Response to Therapy

Findings point to near-term potential for personalized-medicine screenings.
News

Qiagen Develops Leading Solutions for RNA Interference

Qiagen will develop world’s largest collection of validated siRNAs through an extensive validation project.
News

InforSense and Tripos Announce Alliance to Improve Drug Discovery Decision-Making

This alliance enables customers to access and integrate Tripos' discovery informatics technologies within InforSense KDE.
Advertisement